Targeted options may support energy levels, mental clarity, and normal nutrient metabolism
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Despite widespread awareness about the importance of maintaining a healthy weight, the methods traditionally promotedlike calorie-restrictive diets, high-intensity exercise regimens, and fad supplementsoften fall short of delivering consistent, sustainable results
Every individual has different needs and goals
Loren Pickart, who found that it caused older human liver tissue to produce proteins more characteristic of younger tissue.2 3 This resulted in GHK being originally described, specifically, as a liver cell growth factor
Because 5-Amino-1MQ directly influences core metabolic pathways, a cautious and informed approach is essential
